<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="193342">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00575159</url>
  </required_header>
  <id_info>
    <org_study_id>KGI107465</org_study_id>
    <nct_id>NCT00575159</nct_id>
  </id_info>
  <brief_title>A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus</brief_title>
  <official_title>A Double-blind, Randomized, Single Ascending Dose Escalation, Placebo-controlled, Crossover Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK189075 Administered to Subjects With Type 1 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <brief_summary>
    <textblock>
      The purpose of this research study is to look at concentrations of GSK189075 in blood when
      single doses of the drug are taken by mouth in combination with basal insulin. The clinical
      effects of the drug in combination with insulin on the body will also be studied. The
      results will help determine doses of GSK189075 can be studied in the future in the type I
      diabetes mellitus population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood &amp; urine samples:</measure>
    <time_frame>day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events, heart rate, blood pressure, ECG, clinical laboratory tests:</measure>
    <time_frame>screening, check-in, day 1,follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Arm a</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>GSK189075</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm b</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GSK189075</intervention_name>
    <description>investigational drug</description>
    <arm_group_label>Arm a</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo comparator</description>
    <arm_group_label>Arm b</arm_group_label>
    <other_name>GSK189075</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male/female, 18 to 55 years old

          -  Diagnosis of type 1 diabetes mellitus for at least 6 months; and using a continuous
             insulin pump

          -  Willing and able to follow all study-related instructions provided by the site staff.

          -  Willing to provide signed informed consent.

        Exclusion Criteria:

          -  Pregnant or a nursing female.

          -  Have a past or current disease such as heart, liver, kidney, blood, brain, or other
             disease.

          -  Have HIV or hepatitis, or have alcohol or drugs in your system at the screening
             visit.

          -  Have a history of alcohol abuse or have an eating disorder

          -  Have been in another research study in the last month or have taken certain
             medications in the 1 week before study drug would be taken.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Germany</country>
  </removed_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 13, 2013</lastchanged_date>
  <firstreceived_date>December 14, 2007</firstreceived_date>
  <firstreceived_results_disposition_date>March 29, 2012</firstreceived_results_disposition_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adult male and females,</keyword>
  <keyword>type 1 Diabetes mellitus, pharmacokinetics,</keyword>
  <keyword>pharmacodynamics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted -->
</clinical_study>
